Product Name | MF | CAS | Details |
---|
PKI 14-22 amide, myristoylated | C53H100N20O12 | 201422-03-9 | Details |
Peptide 6A | C23H43N9O6 | 73549-32-3 | Details |
PDZ1 Domain inhibitor peptide | C38H61N9O11 | 1315378-73-4 | Details |
Pasireotide | C58H66N10O9 | 396091-73-9 | Details |
Polypyrimidine tract-binding protein 1 isoform b (359-373) | Details |
PG 106 | C51H69N13O9 | 944111-22-2 | Details |
Pep1-AGL | C40H69N11O14S | Details |
PBP 10 | C84H127N24O15+ | 794466-43-6 | Details |
p-Hydroxyhippuryl-His-Leu-OH | C21H27N5O6 | 77697-23-5 | Details |
Pasireotide-d7 | Details |
PAR-3 (1-6) amide (mouse) | C25H36N8O8 | 261521-21-5 | Details |
Plitidepsin | C57H87N7O15 | 137219-37-5 | Details |
Phe-Met-Arg-Phe, amide | C29H42N8O4S | 64190-70-1 | Details |
PKCβpseudosubstrate | C177H294N62O38S3 | 172308-76-8 | Details |
pml-RARalpha fusion protein () | Details |
Phrixotoxin 3 | C176H269N51O48S6 | 880886-00-0 | Details |
Platelet Factor 4 (58-70), human | C76H133N17O18 | 82989-21-7 | Details |
Poly(Tripeptide-6) | Details |
Peptide YY (PYY) (3-36), human | C176H272N52O54 | 126339-09-1 | Details |
Prepro VIP (81-122), human | 111366-38-2 | Details |
Preptin (rat) | 315197-73-0 | Details |
Phosphorylase Kinase β-Subunit Fragment 420-436 | C79H131N31O25S | 150829-21-3 | Details |
Pentapeptide-18 | Details |
Pentapeptide-31 | C19H34N6O8 | 1232137-75-5 | Details |
PHF6 | C36H60N8O9 | 329897-62-3 | Details |
Prepro-Atrial Natriuretic Factor (26-55) (human) | C152H236N38O51S3 | 112160-82-4 | Details |
pep2m | C49H92N18O13S | 243843-42-7 | Details |
Peptide T TFA | C37H56F3N9O18 | 1610056-01-3 | Details |
pep4c | C48H91N17O13S | 243843-43-8 | Details |
Phe-Met-Arg-Phe Like Peptide, Snail Helix aspersa | C44H61N11O10 | 98495-35-3 | Details |
Pramlintide | C171H267N51O53S2.C2H4O2.H2O | 151126-32-8 | Details |
Phenylac-Gln-OH | C13H16N2O4 | 28047-15-6 | Details |
Prepro-Atrial Natriuretic Factor (104-123) (human) | C94H171N31O28 | 112160-83-5 | Details |
Peptide 8 10 | C59H91N13O17S | 156371-22-1 | Details |
Parstatin (human) | C191H330N64O53S3 | 1065755-99-8 | Details |
Poly(A) polymerase gamma (724-734) | Details |
Plecanatide | C65H104N18O26S4 | 467426-54-6 | Details |
PMX 205 | C45H62N10O6 | 514814-49-4 | Details |
Pep-1 uncapped | C136H195N35O33 | 395069-86-0 | Details |
Peptide YY (3-36) (human) Acetate | C180H278N53O54R | 123583-37-9 | Details |
PAR-2 (1-6) (human) | C28H53N7O8 | 202933-49-1 | Details |
Pexiganan acetate | C124H214N32O24 | 172820-23-4 | Details |
Peptide 74 | C62H107N23O20S2 | 132116-39-3 | Details |
Proadrenomedullin (1-20), human | C112H178N36O27 | 150238-87-2 | Details |
Pep2m, myristoylated | C63H118N18O14S | 1423381-07-0 | Details |
Phylloseptin-L2 | C76H126N18O19 | 1100546-22-2 | Details |
pGlu-Pro-Arg-MNA | C23H32N8O7 | 130835-45-9 | Details |
POTE ankyrin domain family member F (795-804) | Details |
Polycystic kidney disease 1 protein (4192-4202) | Details |
Peginesatide | C231H350N62O58S6(C2H4O)n | 913976-27-9 | Details |
Peptide 46 | C100H174N40O31 | 192122-40-0 | Details |
PeptideWE-14 | C72H116N18O24S | 115136-18-0 | Details |
PLP 139-151 | C72H104N20O16S | 131334-43-5 | Details |
Pentagastrin | C37H49N7O9S | 5534-95-2 | Details |
Peptide 401 | C110H192N40O24S4 | 32908-73-9 | Details |
Perindopril Erbumine | C23H43N3O5 | 107133-36-8 | Details |
PAR-4 Agonist Peptide, amide TFA | C36H49F3N8O9 | 1228078-65-6 | Details |
Polymyxin B nonapeptide | C43H74N14O11 | 86408-36-8 | Details |
Pneumocandin B0 | C50H80N8O17 | 135575-42-7 | Details |
Prepro VIP (111-122), human | C53H87N13O21 | 123025-94-5 | Details |
Phosphoramidon | C23H35N3NaO10P | 119942-99-3 | Details |
Protein Kinase C 19-36 | C93H159N35O24 | 113731-96-7 | Details |
Perilipin-2 (129-137) | Details |
Phe-Met-Arg-Phe amide trifluoroacetate | C31H43F3N8O6S | 159237-99-7 | Details |
Peptide Lv (rat) trifluoroacetate salt | 1872441-58-1 | Details |
Physalaemin | C58H84N14O16S | 2507-24-6 | Details |
Peptide YY (PYY), human | C194H295N55O57 | 118997-30-1 | Details |
PAR-1 (1-6) (mouse, rat) | C37H54N10O9 | 140436-67-5 | Details |
PKG Substrate | C35H67N17O11 | 81187-14-6 | Details |
PAR-2 (6-1) amide (mouse, rat) | C29H56N10O7 | 245329-01-5 | Details |
Pentapeptide-3 | C21H37N9O5 | 135679-88-8 | Details |
Parstatin (mouse) | C189H326N58O57S3 | 1065756-01-5 | Details |
PHM-27 (human) | C135H214N34O40S | 87403-73-4 | Details |
PAR-4 (1-6) (human) | C28H41N7O9 | 225779-44-2 | Details |
PMX 53 | C47H65N11O7 | 219639-75-5 | Details |
Pep1-TGL | C41H71N11O15S | Details |
PKA inhibitor fragment (6-22) amide | C80H130N28O24 | 121932-06-7 | Details |
PAR-2 (1-6) (mouse, rat) | C29H55N9O8 | 164081-25-8 | Details |
pGlu-Pro-Arg-MNA monoacetate | C25H36N8O9 | 2070009-26-4 | Details |
Peroxiredoxin-5, mitochondrial (163-172) | Details |
Pro-Adrenomedullin (1-20) (rat) trifluoroacetate salt | C111H177N37O28 | 167699-60-7 | Details |
Parasin I TFA | C??H???N??O??.C?HF?O? | Details |
pep2-SVKI | C60H93N13O18 | 328944-75-8 | Details |
Preptin (human) | 315197-69-4 | Details |
PMEL (25-33) | Details |
pep2-SVKE | C59H89N13O20 | 1315378-76-7 | Details |
PAR-3 (1-6) (human) | C29H45N9O8 | 320347-28-2 | Details |
pep2-EVKI | C62H95N13O19 | 1315378-67-6 | Details |
Peptide T | C35H55N9O16 | 106362-32-7 | Details |
PGLa | C88H162N26O22S | 102068-15-5 | Details |
Preangiotensinogen (11-14) (human) acetate salt | C21H35N7O6 | 102813-98-9 | Details |
PAR-4 Agonist Peptide, amide | C34H48N8O7 | 352017-71-1 | Details |
PM 102 | C235H424N111O64 | 1234564-95-4 | Details |
pep2-AVKI | C60H93N13O17 | 1315378-69-8 | Details |
Prepro VIP (156-170) (human) | C71H106N16O31 | 107902-86-3 | Details |
Pergolide Mesylate Salt | C20H30N2O3S2 | 66104-23-2 | Details |
Peptide C105Y | C97H148N20O23S | 247572-63-0 | Details |
Pressinoic Acid | C33H42N8O10S2 | 35748-51-7 | Details |
PAR-4 (1-6) (mouse) | C33H45N7O8 | 213018-42-9 | Details |
PAR-4 (1-6) amide (human) | C28H42N8O8 | 245443-51-0 | Details |
Product Total: Product Page: | ||||
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |